Heart Blocks Treatment Devices Market Report 2026

Heart Blocks Treatment Devices Market Overview

• Heart Blocks Treatment Devices market size has reached to $3.36 billion in 2025 • Expected to grow to $4.74 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: Cardiovascular Disease Surge Propels Expansion Of Heart Block Treatment Devices Market • Market Trend: Revolutionizing Cardiac Care With Advanced Heart Block Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Heart Blocks Treatment Devices Market?

Heart blocks treatment devices are medical devices used to manage and correct disruptions in the electrical conduction system of the heart, specifically heart block. These devices help regulate the heart's rhythm and ensure proper coordination between the heart's chambers (atria and ventricles). The main types of heart blocks treatment devices are first-degree heart block, second-degree heart block, and third-degree heart block. First-degree heart block is a type of conduction abnormality in which there is a delay in the conduction of electrical signals through the heart's atrioventricular (AV) node. First-degree heart block, pacemaker implantation is typically reserved for rare instances where the blockage significantly affects the person's quality of life or if there are signs of progression to higher degrees of heart block. The various products of heart blocks treatment devices are transcutaneous pacing (TCP), pacemaker, mediation, and follow-up electrophysiology study, which are deployed in hospital testing, home treatment, clinics, and others.

What Is The Heart Blocks Treatment Devices Market Growth Forecast?

The heart blocks treatment devices market size is expected to see strong growth in the next few years. It will grow to $4.74 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to growing adoption of remote patient monitoring, rising investments in cardiac digital health solutions, increasing demand for personalized rhythm management, expansion of home-based cardiac care models, continuous innovation in implantable cardiac devices. Major trends in the forecast period include increasing adoption of advanced pacemaker technologies, rising use of implantable cardiac rhythm devices, growing integration of remote cardiac monitoring systems, expansion of minimally invasive cardiac procedures, enhanced focus on long-term rhythm management.

Global Heart Blocks Treatment Devices Market Segmentation

1) By Clinical Classification: First-Degree Heart Block, Second-Degree Heart Block, Third-Degree Heart Block 2) By Product: Transcutaneous Pacing (TCP), Pacemaker 3) By End-User: Hospitals & Cardiac Care Centers, Clinics, Home-Care & Remote Monitoring Users Subsegments: 1) By First-Degree Heart Block: Cardiac Monitoring Devices, Temporary Pacing Devices (Rare / Symptomatic Cases) 2) By Second-Degree Heart Block: Type I (Wenckebach) Management Devices, Type II Management Devices, Pacemakers 3) By Third-Degree Heart Block: Permanent Pacemakers (Primary Treatment), Cardiac Resynchronization Therapy (CRT) Devices, Temporary Pacing Devices (Acute / Emergency Management)

What Are The Drivers Of The Heart Blocks Treatment Devices Market?

The rising prevalence of cardiovascular disease is expected to propel the growth of the heart blocks treatment devices market going forward. Cardiovascular diseases affect the heart and blood vessels and include conditions such as coronary artery disease, heart failure, and stroke. The rapidly increasing incidence of cardiovascular disease is mostly driven by the aging population, changes in lifestyle and diet, and increasing rates of obesity and diabetes, where heart blocks treatment devices can be used to treat cardiovascular disorders by addressing abnormalities or defects in the structures and blocks of the heart. For instance, in March 2024, according to the according to GOV.UK, a UK-based government services and information provider, in the financial year ending 2023, over 1,862,500 people in England, about 3% of the population had been diagnosed with coronary heart disease (CHD) by a GP. Therefore, the rising prevalence of cardiovascular disease is driving the growth of the heart blocks treatment devices industry. An increase in the size of the aging population is expected to drive the growth of the heart block treatment device market. An aging population refers to a situation where the proportion of older people in a population is steadily increasing. The aging population is a significant factor contributing to the increasing prevalence of heart block. As individuals grow older, the risk of developing cardiac conduction system abnormalities, such as heart block, rises, thus increasing the need for heart block treatment devices. For instance, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, in 2022, there were 12.7 million people aged 65 or older in the UK, representing 19% of the total population. This number is projected to rise to 22.1 million by 2072, accounting for 27% of the population. Therefore, the aging population is expected to drive demand for the heart block treatment device market.

Key Players In The Global Heart Blocks Treatment Devices Market

Major companies operating in the heart blocks treatment devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Nihon Kohden Corporation, ZOLL Medical Corporation, LivaNova PLC, Osypka Medical GmbH, Shree Pacetronix Ltd., EBR Systems Inc., Medico S.p.A., Cook Medical, B. Braun SE, Oscor Inc., Pacetronix Ltd., Fukuda Denshi Co. Ltd., Teleflex Incorporated, NIPRO Corporation

Global Heart Blocks Treatment Devices Market Trends and Insights

Major companies operating in the heart block treatment device market are focusing on technological advancements such as dual-chamber pacemakers to provide reliable services to customers. Dual-chamber pacemakers which refer to the technology of leadless pacing systems for treating abnormal or slow heart rhythms. For instance, in November 2023, Abbott Laboratories, a US-based medical device and health care company, launched a dual-chamber pacemaker with the first U.S. implants, as more than 80% of people who need a pacemaker require pacing in two chambers of the heart, the right atrium and right ventricle. The company developed the i2i technology to utilize high-frequency pulses, relaying messages through the naturally conductive characteristics of the body’s blood between each leadless pacemaker.

Regional Outlook

North America was the largest region in the heart blocks treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Heart Blocks Treatment Devices Market?

The heart blocks treatment devices market consists of sales of implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and leadless pacemakers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.